PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies.
about
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician.Molecular Imaging of PARP.Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma.Current status and future challenges for molecular imaging.Target engagement imaging of PARP inhibitors in small-cell lung cancer.A PET imaging agent for evaluating PARP-1 expression in ovarian cancer.
P2860
PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
PET of Poly (ADP-Ribose) Polym ...... nt and First In-Human Studies.
@en
PET of Poly
@nl
type
label
PET of Poly (ADP-Ribose) Polym ...... nt and First In-Human Studies.
@en
PET of Poly
@nl
prefLabel
PET of Poly (ADP-Ribose) Polym ...... nt and First In-Human Studies.
@en
PET of Poly
@nl
P2093
P2860
P1433
P1476
PET of Poly (ADP-Ribose) Polym ...... nt and First In-Human Studies.
@en
P2093
Andrea Wang-Gillam
Benjamin Tan
Christopher Bognar
Delphine L Chen
Frank J Brooks
Jacquelyn T Engle
Katherine J Spayd
Loren S Michel
Richard Laforest
P2860
P304
P356
10.1148/RADIOL.2016161929
P407
P577
2016-11-14T00:00:00Z